{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T09:45:27Z","timestamp":1775727927183,"version":"3.50.1"},"reference-count":15,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T00:00:00Z","timestamp":1708300800000},"content-version":"vor","delay-in-days":18,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["542\/20"],"award-info":[{"award-number":["542\/20"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","award":["1049171"],"award-info":[{"award-number":["1049171"]}],"id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Protocols"],"published-print":{"date-parts":[[2024,2]]},"abstract":"Abstract<\/jats:title>\n Eosinophilic esophagitis (EoE) is an emerging chronic T helper type 2 (Th2)\u2010associated, allergic, and immune\u2010mediated disease, characterized histologically by eosinophil\u2010predominant mucosal inflammation and clinically by esophageal dysfunction. Over the past years, the prevalence of EoE has dramatically increased globally. Until recently, most studies of EoE focused on using human biopsies, which are also used for diagnostic purposes, or esophageal epithelial cell lines, which led to major advances in the understanding of EoE. Despite this, a robust mouse model that mimics human disease is still crucial for both understanding disease pathogenesis and as a preclinical model for testing future therapeutics. Herein, we describe a highly reproducible and robust model of EoE that can be performed using wild\u2010type mice by ear sensitization with oxazolone (OXA) followed by intraesophageal challenges. Experimental EoE elicited by OXA mimics the main histopathological features of human EoE, including intraepithelial eosinophilia, epithelial and lamina propria thickening, basal cell hyperplasia, and fibrosis. \u00a9 2024 The Authors. Current Protocols published by Wiley Periodicals LLC.<\/jats:p>\n \n Basic Protocol<\/jats:bold>\n : Induction of EoE in mice using oxazolone\n <\/jats:p>\n \n Support Protocol 1<\/jats:bold>\n : Preparing the mouse esophagus for histological analysis\n <\/jats:p>\n \n Support Protocol 2<\/jats:bold>\n : Assessment of epithelial and lamina propria thickness using H&E staining\n <\/jats:p>\n \n Support Protocol 3<\/jats:bold>\n : Assessment of eosinophilic infiltration using anti\u2010MBP and basal cell proliferation using anti\u2010Ki\u201067 staining\n <\/jats:p>\n \n Support Protocol 4<\/jats:bold>\n : Flow cytometry of mouse esophageal samples\n <\/jats:p>\n \n Support Protocol 5<\/jats:bold>\n : ELISA on protein lysates of esophageal samples\n <\/jats:p>","DOI":"10.1002\/cpz1.993","type":"journal-article","created":{"date-parts":[[2024,2,19]],"date-time":"2024-02-19T06:24:31Z","timestamp":1708323871000},"source":"Crossref","is-referenced-by-count":1,"title":["A Mouse Model for Eosinophilic Esophagitis (EoE)"],"prefix":"10.1002","volume":"4","author":[{"given":"Anish","family":"Dsilva","sequence":"first","affiliation":[{"name":"Department of Clinical Microbiology and Immunology Tel Aviv University Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shmulik","family":"Avlas","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology Tel Aviv University Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natalie","family":"Rhone","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology Tel Aviv University Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michal","family":"Itan","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology Tel Aviv University Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1626-3019","authenticated-orcid":false,"given":"Ariel","family":"Munitz","sequence":"additional","affiliation":[{"name":"Department of Clinical Microbiology and Immunology Tel Aviv University Israel"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2024,2,19]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1053\/J.GASTRO.2005.06.027"},{"key":"e_1_2_11_3_1","doi-asserted-by":"crossref","unstructured":"Al\u2010Horani R. A. &Chiles R.(n.d.).First Therapeutic Approval for Eosinophilic Esophagitis.https:\/\/doi.org\/10.3390\/gastroent13030024","DOI":"10.3390\/gastroent13030024"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296781"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.2147\/JAA.S121092"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/ALL.15510"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1084\/JEM.188.10.1929"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/J.1365\u20102222.2006.02456.X"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1101\/pdb.prot073411"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1053\/J.GASTRO.2010.05.001"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/J.CELL.2018.04.037"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S40107"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.08.068"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1053\/J.GASTRO.2017.06.065"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10112874"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0000000000001909"}],"container-title":["Current Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpz1.993","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpz1.993","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpz1.993","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T08:45:38Z","timestamp":1775724338000},"score":1,"resource":{"primary":{"URL":"https:\/\/currentprotocols.onlinelibrary.wiley.com\/doi\/10.1002\/cpz1.993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["10.1002\/cpz1.993"],"URL":"https:\/\/doi.org\/10.1002\/cpz1.993","archive":["Portico"],"relation":{},"ISSN":["2691-1299","2691-1299"],"issn-type":[{"value":"2691-1299","type":"print"},{"value":"2691-1299","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2]]},"article-number":"e993"}}